# Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection

> **NCT06752083** · — · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 289 (actual)

## Conditions studied

- HPV Infection

## Interventions

- **DIETARY_SUPPLEMENT:** AHCC® (Active Hexose Correlated Compound)
- **BIOLOGICAL:** Gardasil 9®

## Key facts

- **NCT ID:** NCT06752083
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-02
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-15
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752083, "Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06752083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*